Nontraumatic subarachnoid hemorrhage. Nontraumatic subarachnoid hemorrhage
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group will receive an oral capsule of zinc sulfate containing 50 mg of elemental zinc (Alhavi Pharmaceutical Co., Tehran, Iran) either via gavage o
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with non-traumatic subarachnoid hemorrhage Consent to participate in the study
Exclusion criteria
Exclusion criteria: Contraindications to zinc use, including allergy, pregnancy or lactation, malignancy, or neurodegenerative diseases. Medical conditions affecting drug metabolism, such as hepatic or renal disorders, or history of craniotomy. Short hospitalization duration in the treatment center (less than 10 days).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sequential Organ Failure Assessment score. Timepoint: v. Method of measurement: Sequential Organ Failure Assessment scale.;Glasgow Coma Scale score. Timepoint: First, third, seventh, and tenth days after the intervention. Method of measurement: Glasgow Coma Scale.;APACHE II score. Timepoint: First day of intervention. Method of measurement: APACHE II scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Death. Timepoint: After the intervention. Method of measurement: Patient file.;Occurrence of complications. Timepoint: Beginning of intervention until the tenth day after intervention. Method of measurement: History and physical examination.;Length of hospital stay. Timepoint: After the intervention. Method of measurement: Patient file. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Behnam Arabzadeh
Arak University of Medical Sciences
Outcome results
None listed